ICICI Direct's research report on Cipla
Revenues remained flat at Rs 4376 crore YoY due to 25.1% YoY decline in US revenues to Rs 856 crore, attributable mainly to high base of gSensipar. On the other hand, domestic formulations grew 15.3% to Rs 1730 crore. EBITDA margins fell 735 bps YoY to 14.5% mainly due to a sharp drop in gross margins (61.4% vs. 66.3% in Q4FY19). EBITDA de-grew 34.1% YoY to Rs 633.5 crore. Net profit fell 33.0% YoY to Rs 246.0 crore due to a below expected operational performance. Delta vis-à-vis EBITDA was due to lower depreciation.
Outlook
Our revised target price is Rs 670 based on 22x FY22E EPS Rs 30.2. We upgrade the stock from HOLD to BUY
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.